| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2981 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2534 | 2020 |
| A whole-genome association study of major determinants for host control of HIV-1 J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ... science 317 (5840), 944-947, 2007 | 1594 | 2007 |
| HIV evolution: CTL escape mutation and reversion after transmission AJ Leslie, KJ Pfafferott, P Chetty, R Draenert, MM Addo, M Feeney, ... Nature medicine 10 (3), 282-289, 2004 | 1086 | 2004 |
| HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ... Nature 568 (7751), 244-248, 2019 | 832 | 2019 |
| HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ... Nature medicine 16 (4), 460-465, 2010 | 693 | 2010 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 642 | 2021 |
| Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 632 | 2012 |
| Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ... Journal of virology 80 (7), 3617-3623, 2006 | 561 | 2006 |
| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 512 | 2009 |
| Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1 J Martinez-Picado, AV Savara, L Sutton, RT D’Aquila Journal of virology 73 (5), 3744-3752, 1999 | 497 | 1999 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 440 | 2021 |
| Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection R Draenert, S Le Gall, KJ Pfafferott, AJ Leslie, P Chetty, C Brander, ... The Journal of experimental medicine 199 (7), 905-915, 2004 | 392 | 2004 |
| Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs C Katlama, SG Deeks, B Autran, J Martinez-Picado, J Van Lunzen, ... The Lancet 381 (9883), 2109-2117, 2013 | 385 | 2013 |
| Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells MJ Buzon, E Martin-Gayo, F Pereyra, Z Ouyang, H Sun, JZ Li, M Piovoso, ... Journal of virology 88 (17), 10056-10065, 2014 | 351 | 2014 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia Q Zhang, P Bastard, A Cobat, JL Casanova Nature 603 (7902), 587-598, 2022 | 344 | 2022 |
| Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni, J Noack, YJ Park, ... Nature 598 (7880), 342-347, 2021 | 340 | 2021 |
| Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway N Izquierdo-Useros, M Naranjo-Gómez, J Archer, SC Hatch, I Erkizia, ... Blood, The Journal of the American Society of Hematology 113 (12), 2732-2741, 2009 | 317 | 2009 |
| Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report RK Gupta, D Peppa, AL Hill, C Gálvez, M Salgado, M Pace, LE McCoy, ... The Lancet HIV 7 (5), e340-e347, 2020 | 308 | 2020 |
| Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides N Izquierdo-Useros, M Lorizate, MC Puertas, MT Rodriguez-Plata, ... PLoS biology 10 (12), e1001448, 2012 | 295 | 2012 |
